Cigna (CGN) Stock Price & Analysis
CGN Stock Chart & Stats
- Day’s Range
- EUR 266.90 - EUR 270.60
- 52-Week Range
- EUR 210.05 - EUR 282.00
- Previous Close
- EUR 266.10
- Volume
- N/A
- Average Volume (3M)
- 22
- Market Cap
- EUR 70.56B
- Enterprise Value
- EUR 104.94B
- Total Cash (Recent Filing)
- EUR 6.30B
- Total Debt (Recent Filing)
- EUR 31.88B
- Price to Earnings (P/E)
- 12.3
- Beta
- 0.12
- Next Earnings
- Nov 05, 2026 (Est.)
- EPS Estimate
- 6.73
- Next Dividend Ex-Date
- Dec 03, 2026
- Dividend Yield
- 1.98%
Bulls Say, Bears Say
Bulls Say
Diversified Growth Platforms
Cigna combines insurance with pharmacy, specialty, behavioral health, and care-management services, creating multiple recurring revenue streams. Recent growth across both major platforms indicates broad demand and reduces reliance on a single product or customer segment over the coming quarters.
Strong Cash Generation
A large operating free-cash-flow base supports investment in technology, modernization, debt management, and shareholder returns without depending entirely on external financing. The close relationship between free cash flow and earnings also indicates meaningful cash conversion, supporting financial resilience.
Retention And Technology Advantage
Very high pharmacy-benefit retention supports recurring revenue and demonstrates customer stickiness. AI-enabled care coordination and measurable reductions in avoidable admissions can improve affordability and outcomes, strengthening Cigna’s service proposition and competitive position over time.
Bears Say
Medical Cost Pressure
Sustained high medical-cost inflation can compress insurance margins when claims rise faster than premiums or pricing resets. Although guidance was maintained, continued pressure raises the risk that elevated utilization and provider costs reduce earnings durability across future reporting periods.
PBS Transition Earnings Pressure
The transition to the rebate-free Signature model is requiring substantial investment and has already reduced Pharmacy Benefit Services earnings. Similar transition expenses are expected in 2027, creating a multi-period drag on margins before the intended operating benefits can emerge.
Meaningful Leverage
Leverage is manageable but still meaningful, which limits balance-sheet flexibility compared with stronger capital profiles. Debt obligations can constrain capital allocation and make it harder to absorb margin volatility or fund modernization if operating conditions weaken over the next several quarters.
Cigna News
CGN FAQ
What was Cigna’s price range in the past 12 months?
What is Cigna’s market cap?
When is Cigna’s upcoming earnings report date?
How were Cigna’s earnings last quarter?
Is Cigna overvalued?
Does Cigna pay dividends?
What is Cigna’s EPS estimate?
How many shares outstanding does Cigna have?
What happened to Cigna’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Cigna?
What is the TipRanks Smart Score and how is it calculated?
Cigna Stock Smart Score
Company Description
Cigna
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Brian C. Evanko
- Employees
- 66,685
- Website
- www.thecignagroup.com
- Address
- 900 Cottage Grove Road, Bloomfield, CT, 06002, US
Cigna (CGN) Earnings & Revenues
CGN Earnings Call
Earnings Call SentimentPositive
The call conveyed strong operational and financial momentum driven by specialty drug growth, Evernorth and Cigna Healthcare outperformance, AI-enabled clinical initiatives with measurable outcomes, solid revenue and EPS beats, and an upgraded full-year EPS outlook. Offsetting items include PBS earnings pressure from transition investments and economic shifts due to biosimilars, moderating GLP-1 utilization, persistently elevated medical cost trends, IDR-related affordability concerns, and one-time special charges. Overall, the positive drivers (revenue growth, margin gains in Specialty, upgraded guidance, retention/new-business strength, AI initiatives) materially outweigh the manageable challenges described.
View all DE:CGN earnings summariesCGN Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 5 | 3 |
| Technical Analysis | 5 | 5 | 0 |
| Moving Averages | 9 | 0 | 3 |









